Abbott enters into agreement with Inpeco to expand laboratory automation capabilites

04-Mar-2005

Abbott announced that it has entered into an agreement with Inpeco S.p.A. to expand its Laboratory automation capabilities. Through the agreement, Abbott plans to offer a suite of automation solutions that can be customized to address key needs within the laboratory, enhancing the consistency and efficiency of the diagnostic testing process.

"Laboratories are looking at automation to help them address labor shortages, improve safety and reduce errors," said Douglas C. Bryant, vice president, Global Commercial Operations, Diagnostics Division, Abbott. "Many of Abbott's diagnostic instruments and software already address some of these challenges. However, this agreement allows Abbott to offer a broader range of automation solutions that can be customized to support the lab's unique workflow needs."

Under the terms of the agreement, Abbott obtains non-exclusive rights to distribute and market Inpeco laboratory automation equipment worldwide. Additionally, Abbott will have access to new lab automation technologies developed by Inpeco. This gives Abbott the ability to incorporate technological advancements, including information technology and robotics, into future automation solutions.

Abbott and Inpeco will partner to design, develop and commercialize interfaces between Abbott's ARCHITECT® and CELL-DYN® family of analyzers and Inpeco's suite of modular, laboratory automation components to create an enhanced pre/post-analytical workcell, an immunochemistry track workcell, a hematology track workcell or a customized combination of the three. Abbott will also offer laboratories additional flexibility by utilizing an open architecture. This open-system approach gives laboratories the ability to customize a system that best meets their needs.

https://www.chemeurope.com/en/news/43948/abbott-enters-into-agreement-with-inpeco-to-expand-laboratory-automation-capabilites.html